Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Circle8 Group, Inc.

Circle8 Group, Inc. (CIRC) Stock Overview

Explore Circle8 Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CIRC●NASDAQ
HealthcareMedical - Pharmaceuticals
$0.70
$0.02(3.21%)
U.S. Market opens in 11h 42m

Circle8 Group, Inc. (CIRC)

Meyka AI Score

Z

Key Financials

Market Cap63M
P/E RatioN/A
EPS (TTM)$-0.44
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$0.53
3 Months$0.00
1 Year Target$0.00

CIRC Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Circle8 Group, Inc. (NASDAQ: CIRC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Circle8 Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CIRC on the NASDAQ shows an RSI of 45.31, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Circle8 Group, Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 63M. Combined with our AI analysis, these give both institutional and retail investors a clear view of CIRC on the NASDAQ.

Price Performance (NASDAQ: CIRC)

1-Day Change
-3.21%
5-Day Change
2.49%
1-Month Change
-18.60%
3-Month Change
-9.33%
6-Month Change
-9.33%
Year-to-Date (YTD) Change
-9.33%
1-Year Change
-9.33%
3-Year Change
-9.33%
5-Year Change
-9.33%
All-Time (Max) Change
-9.33%

Contact Information

https://www.circle8group.com
31 30 600 150
270 Sylvan Avenue, Suite 2230, Englewood Cliffs, NJ, 07632

Company Facts

3,000 Employees
IPO DateAug 27, 2021
CountryUS
Actively Trading

Frequently Asked Questions